Compare BBWI & SHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BBWI | SHC |
|---|---|---|
| Founded | 1963 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 4.4B |
| IPO Year | 1994 | 2020 |
| Metric | BBWI | SHC |
|---|---|---|
| Price | $17.93 | $15.24 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 15 | 7 |
| Target Price | ★ $24.88 | $20.33 |
| AVG Volume (30 Days) | ★ 6.3M | 3.8M |
| Earning Date | 05-28-2026 | 05-05-2026 |
| Dividend Yield | ★ 4.36% | N/A |
| EPS Growth | N/A | ★ 68.75 |
| EPS | ★ 0.90 | 0.09 |
| Revenue | ★ $7,291,000,000.00 | $1,163,617,000.00 |
| Revenue This Year | N/A | $7.51 |
| Revenue Next Year | $2.19 | $6.00 |
| P/E Ratio | ★ $20.80 | $166.89 |
| Revenue Growth | N/A | ★ 5.74 |
| 52 Week Low | $14.28 | $10.80 |
| 52 Week High | $33.96 | $19.85 |
| Indicator | BBWI | SHC |
|---|---|---|
| Relative Strength Index (RSI) | 45.88 | 44.39 |
| Support Level | $16.59 | $15.16 |
| Resistance Level | $20.13 | $16.41 |
| Average True Range (ATR) | 0.98 | 0.43 |
| MACD | 0.12 | -0.06 |
| Stochastic Oscillator | 42.25 | 29.39 |
Bath & Body Works is a specialty home fragrance and fragrant body care retailer operating under the Bath & Body Works, C.O. Bigelow, and White Barn brands. The company generates most of its business in North America, with just 4% of sales from international markets in fiscal 2025. For fiscal 2025, 77% of sales stemmed from the brick-and-mortar network (which was composed of more than 1,900 retail stores), similar to 2024 levels, as consumer shopping patterns remained normal. Future growth is expected from store upgrades, digital and international channels, as well as adjacent category expansions like men's and lip.
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.